Phyllodes tumour

Exam relevance: in 1 of more than 150 board exam reports · rank 171

Specialty
Gynaecology · Breast
Images
Endoscopy & gross 1
Exam relevance
1 of more than 150 reports · rank 171
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (1)
  2. Definition
  3. Classification
  4. Occurrence & epidemiology
  5. Clinical features
  6. Histology
  7. Diagnosis
  8. Treatment principles
  9. Keep learning in the app
  10. Further reading (selection)
  11. Cross-references

Images (1)

Phyllodes tumour – endoscopyEndoscopy & gross
Phyllodes tumour – endoscopyImage: Yu T, Li R, Cai C. (Frontiers in oncology 2026) · CC BY 4.0 · Source

Definition

  • Rare biphasic fibroepithelial tumour of the breast with a morphological continuum from benign to malignant, accounting for 0.3–1% of primary breast tumours.

Classification

  • The WHO distinguishes benign, borderline and malignant tumours by nuclear atypia, stromal cellularity, mitoses, tumour margin and stromal overgrowth; 60–75% are benign.
  • Benign tumours have fewer than 5 mitoses per 10 HPF, borderline tumours 5–9 and malignant tumours 10 or more.

Occurrence & epidemiology

Epidemiology

  • Mainly women aged 40 to 50 years are affected; benign forms tend to occur at a younger age than borderline and malignant tumours.

Clinical features

  • Through rapid growth the tumour can bulge the breast, stretch the skin and ulcerate; dilated skin veins and nipple changes occur.
  • Enlarged axillary lymph nodes are relatively common and usually reactive, whereas nodal metastases are very rare.

Histology

  • Histology shows a hypercellular stroma with an increased intracanalicular growth pattern and leaf-like structures, lined by a double layer of epithelium, projecting into cystic spaces.

Diagnosis

  • Mammography usually shows well-defined, dense masses; ultrasound shows a solid hypoechoic mass, usually with posterior acoustic enhancement and often increased vascularity on Doppler, cystic areas being more typical of malignant forms.
  • Distinction from fibroadenoma is difficult, especially on core biopsy; imaging alone cannot reliably distinguish benign from malignant forms.

Treatment principles

  • Treatment consists of complete excision with clear margins, as phyllodes tumours frequently recur after incomplete resection; according to current evidence, a wide safety margin beyond a clear margin does not reliably reduce the recurrence risk.
  • Surgical staging of the axilla is usually unnecessary because lymphatic spread is rare.
  • Radiotherapy may be considered for malignant tumours; because of the tendency to recur, regular clinical and ultrasound follow-up is arranged.

Specific treatment regimens with drugs and doses are covered in the GynFuchs app.

Keep learning in the app

In the GynFuchs app you can learn Phyllodes tumour with flashcards, exam questions and image tasks (colposcopy, ultrasound, CTG) – free, in your browser or as an app.

Open in browser  About GynFuchs →

Further reading (selection)

  1. StatPearls: Phyllodes Tumor of the Breast (NCBI Bookshelf)
  2. Phyllodes tumors of the breast: A comprehensive review of diagnosis, treatment, and follow-up

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.

Related pages: Triple-negative breast cancer · B3 lesions of the breast · Ductal carcinoma in situ (DCIS)

Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.